Company Profile

BioKier Inc
Profile last edited on: 6/7/18      CAGE: 77YX3      UEI: FWDTKYZ61V87

Business Identifier: medical foods and drugs for diabetes and related disorders
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

105 Green Willow Court
Chapel Hill, NC 27514
Location: Single
Congr. District: 04
County: Orange

Public Profile

BioKier Inc is a pharmaceutical company developing new proprietary medical foods and drugs for diabetes and related disorders. The company's primary product is a novel oral capsule for type 2 diabetes with potential effects in metabolic syndrome and obesity. The active ingredient of BioKier’s lead product, L-glutamine, is a natural compound abundant in food and has been shown to be an active and potent natural gut hormone secretagogue acting on colorectal L-cells

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 2 NIH $4,727,118
Project Title: Development of an Oral Therapeutic to Mimic the Anti-Diabetic Effects of Gastric Bypass Surgery

Key People / Management

  Bennett Love -- VP and Chief Financial Officer

  Jerzy Szewczyk -- Co-Founder, CEO and CSO

  Joann Giannone -- Operations

  Roger D Nolan -- Co-Founder, President And Coo